Terms: = Pancreatic cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1
88 results:
1. IFN‑γ induces apoptosis in gemcitabine‑resistant pancreatic cancer cells.
Kong X; Cheng D; Xu X; Zhang Y; Li X; Pan W
Mol Med Rep; 2024 May; 29(5):. PubMed ID: 38488034
[TBL] [Abstract] [Full Text] [Related]
2. NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and bcrp promotes breast cancer progression.
Zhao CC; Sun X; Chen J; Geng BD
Thorac Cancer; 2024 Apr; 15(10):820-829. PubMed ID: 38409918
[TBL] [Abstract] [Full Text] [Related]
3. pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1.
Guo Y; Cui J; Liang X; Chen T; Lu C; Peng T
Int Immunopharmacol; 2024 Jan; 127():111407. PubMed ID: 38134594
[TBL] [Abstract] [Full Text] [Related]
4. Identification and Clinical Significance of pancreatic cancer Stem Cells and Their Chemotherapeutic Drug Resistance.
Kuo YC; Kou HW; Hsu CP; Lo CH; Hwang TL
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108495
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA GAS5 Regulates Gemcitabine Resistance in pancreatic Carcinoma by Targeting miRNA-21.
Huang K; Yang G
Ann Clin Lab Sci; 2023 Mar; 53(2):222-229. PubMed ID: 37094852
[TBL] [Abstract] [Full Text] [Related]
6. Increased expression of the pathological O-glycosylated form of oncofetal fibronectin in the multidrug resistance phenotype of cancer cells.
Reis JSD; Santos MARDC; da Costa KM; Freire-de-Lima CG; Morrot A; Previato JO; Previato LM; da Fonseca LM; Freire-de-Lima L
Matrix Biol; 2023 Apr; 118():47-68. PubMed ID: 36882122
[TBL] [Abstract] [Full Text] [Related]
7. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
Zhang Z; Xu Y
Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
[TBL] [Abstract] [Full Text] [Related]
8. The role of catechin in electroporation of pancreatic cancer cells - Effects on pore formation and multidrug resistance proteins.
Michel O; Szlasa W; Baczyńska D; Saczko J; Tarek M; Kulbacka J
Bioelectrochemistry; 2022 Oct; 147():108199. PubMed ID: 35841647
[TBL] [Abstract] [Full Text] [Related]
9. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer.
Gu J; Huang W; Wang X; Zhang J; Tao T; Zheng Y; Liu S; Yang J; Chen ZS; Cai CY; Li J; Wang H; Fan Y
Mol Cancer; 2022 May; 21(1):112. PubMed ID: 35538494
[TBL] [Abstract] [Full Text] [Related]
10. Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma.
Li F; Aljahdali IAM; Zhang R; Nastiuk KL; Krolewski JJ; Ling X
J Exp Clin Cancer Res; 2021 Aug; 40(1):254. PubMed ID: 34384473
[TBL] [Abstract] [Full Text] [Related]
11. Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness.
Thakur A; Ung J; Tomaszewski EN; Schienschang A; LaBrie TM; Schalk DL; Lum LG
Oncoimmunology; 2021 Jun; 10(1):1930883. PubMed ID: 34123574
[TBL] [Abstract] [Full Text] [Related]
12. Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition.
Ramaker RC; Hardigan AA; Gordon ER; Wright CA; Myers RM; Cooper SJ
BMC Cancer; 2021 May; 21(1):632. PubMed ID: 34049503
[TBL] [Abstract] [Full Text] [Related]
13. The inhibition of ABCB1/MDR1 or abcg2/bcrp enables doxorubicin to eliminate liver cancer stem cells.
Yin W; Xiang D; Wang T; Zhang Y; Pham CV; Zhou S; Jiang G; Hou Y; Zhu Y; Han Y; Qiao L; Tran PH; Duan W
Sci Rep; 2021 May; 11(1):10791. PubMed ID: 34031441
[TBL] [Abstract] [Full Text] [Related]
14. Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancer.
Zhang Z; Xu Y; Zhao C
Cancer Med; 2021 May; 10(10):3332-3345. PubMed ID: 33934523
[TBL] [Abstract] [Full Text] [Related]
15. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
[TBL] [Abstract] [Full Text] [Related]
16. Rational drug design of 6-substituted 4-anilino-2-phenylpyrimidines for exploration of novel abcg2 binding site.
Silbermann K; Li J; Namasivayam V; Stefan SM; Wiese M
Eur J Med Chem; 2021 Feb; 212():113045. PubMed ID: 33454462
[TBL] [Abstract] [Full Text] [Related]
17. Regulation of abcg2 expression by Wnt5a through FZD7 in human pancreatic cancer cells.
Zhang Z; Gao S; Xu Y; Zhao C
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200805
[TBL] [Abstract] [Full Text] [Related]
18. cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development.
Dzobo K; Ganz C; Thomford NE; Senthebane DA
OMICS; 2021 Feb; 25(2):81-92. PubMed ID: 33170084
[TBL] [Abstract] [Full Text] [Related]
19. NRF2 Knockdown Resensitizes 5-Fluorouracil-Resistant pancreatic cancer Cells by Suppressing HO-1 and abcg2 Expression.
Kim EJ; Kim YJ; Lee HI; Jeong SH; Nam HJ; Cho JH
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629871
[TBL] [Abstract] [Full Text] [Related]
20. Activation of GLP-1 receptor enhances the chemosensitivity of pancreatic cancer cells.
Zhao HJ; Jiang X; Hu LJ; Yang L; Deng LD; Wang YP; Ren ZP
J Mol Endocrinol; 2020 Feb; 64(2):103-113. PubMed ID: 31855560
[TBL] [Abstract] [Full Text] [Related]
[Next]
